We are live on ! Find out more
RBC

Romano Brothers & Co Portfolio holdings

AUM $994M
1-Year Est. Return 41.36%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+41.36%
3 Year Est. Return
+100.69%
5 Year Est. Return
10 Year Est. Return
AUM
$643M
AUM Growth
-$28.4M
Cap. Flow
-$684K
Cap. Flow %
-0.11%
Top 10 Hldgs %
22.41%
Holding
310
New
3
Increased
86
Reduced
141
Closed
11

Top Buys

Rank Stock Value
1
SEM
Select Medical
SEM
+$1.2M
2
ENPH icon
Enphase Energy
ENPH
+$1.19M
3
ABBV icon
AbbVie
ABBV
+$1.17M
4
CSCO icon
Cisco
CSCO
+$937K
5
ABT icon
Abbott
ABT
+$885K

Top Sells

Rank Stock Value
1
MKSI icon
MKS Inc
MKSI
+$1.68M
2
ATVI
Activision Blizzard
ATVI
+$734K
3
LH icon
Labcorp
LH
+$556K
4
JNJ icon
Johnson & Johnson
JNJ
+$525K
5
VZ icon
Verizon
VZ
+$504K

Sector Composition

Rank Sector Weight
1 Technology 20%
2 Healthcare 15.79%
3 Industrials 14.23%
4 Financials 7.79%
5 Consumer Discretionary 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
201
General Dynamics
GD
$104B
$511K 0.08%
2,312
-3
-0.1% -$664
AGG icon
202
iShares Core US Aggregate Bond ETF
AGG
$137B
$510K 0.08%
5,418
+64
+1% +$6.16K
TMO icon
203
Thermo Fisher Scientific
TMO
$213B
$485K 0.08%
958
BX icon
204
Blackstone
BX
$102B
$468K 0.07%
4,369
+4
+0.1% +$417
AAP icon
205
Advance Auto Parts
AAP
$3.35B
$457K 0.07%
8,165
-550
-6% -$36.8K
EW icon
206
Edwards Lifesciences
EW
$49.6B
$453K 0.07%
6,537
CMCSA icon
207
Comcast
CMCSA
$85B
$445K 0.07%
10,033
-62
-0.6% -$2.77K
IART icon
208
Integra LifeSciences
IART
$1.29B
$444K 0.07%
11,614
EPD icon
209
Enterprise Products Partners
EPD
$82.3B
$442K 0.07%
16,144
-100
-0.6% -$2.67K
DD icon
210
DuPont de Nemours
DD
$18.5B
$436K 0.07%
4,652
-301
-6% -$28.3K
USB icon
211
US Bancorp
USB
$98.2B
$432K 0.07%
13,077
+649
+5% +$23.6K
VGK icon
212
Vanguard FTSE Europe ETF
VGK
$30.7B
$432K 0.07%
7,455
+550
+8% +$33.5K
IWF icon
213
iShares Russell 1000 Growth ETF
IWF
$121B
$423K 0.07%
6,364
BAC icon
214
Bank of America
BAC
$435B
$421K 0.07%
15,376
-156
-1% -$4.62K
XEL icon
215
Xcel Energy
XEL
$48.8B
$418K 0.07%
7,313
-63
-0.9% -$3.79K
SJM icon
216
J.M. Smucker
SJM
$12.7B
$417K 0.06%
3,389
-225
-6% -$32K
XLP icon
217
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$416K 0.06%
6,044
-156
-3% -$11.4K
IXUS icon
218
iShares Core MSCI Total International Stock ETF
IXUS
$58.3B
$415K 0.06%
6,920
-500
-7% -$31.2K
DXC icon
219
DXC Technology
DXC
$1.82B
$412K 0.06%
19,787
+1,800
+10% +$41.3K
PLD icon
220
Prologis
PLD
$135B
$411K 0.06%
3,661
+145
+4% +$17.7K
XYL icon
221
Xylem
XYL
$27.3B
$410K 0.06%
4,500
IR icon
222
Ingersoll Rand
IR
$32.6B
$407K 0.06%
6,384
TSM icon
223
TSMC
TSM
$2.1T
$397K 0.06%
4,567
GS icon
224
Goldman Sachs
GS
$300B
$387K 0.06%
1,197
+20
+2% +$6.68K
PDCO
225
DELISTED
Patterson Companies, Inc.
PDCO
$385K 0.06%
12,990
-200
-2% -$6.35K

Similar funds

Romano Brothers & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Romano Brothers & Co held 310 positions worth $643M, down 4.2% from $671M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.5%. Romano Brothers & Co opened 3 new positions and exited 11, leaving the 310-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Romano Brothers & Co's largest Q3 2023 buy was Select Medical: 77,395 shares worth $1.05M.
  • Romano Brothers & Co added most to Enphase Energy in Q3 2023, an estimated $1.19M increase.
  • Romano Brothers & Co's biggest Q3 2023 reduction was MKS Inc, cutting an estimated $1.68M.
  • Romano Brothers & Co fully exited Ultra Clean Holdings in Q3 2023, selling an estimated $265K.
  • Romano Brothers & Co's ten largest holdings make up 22% of its $643M portfolio in Q3 2023.
  • Romano Brothers & Co opened 3 new positions and closed 11 in Q3 2023.
  • Romano Brothers & Co's portfolio value fell 4.2% quarter-over-quarter to $643M.

Based on Romano Brothers & Co's 13F filing for Q3 2023, filed 17 Oct 2023.